Engineered “mini livers” could be injected as an alternative to transplantation

A technology developed by Professor Sangeeta Bhatia and colleagues uses hepatocytes injected with hydrogel microspheres to form liver-like structures, offering an alternative to liver transplants. The cells remain viable in mice for two months and could serve as a bridge to transplantation while researchers explore immune system evasion methods.